Company intelligence / Profile preview

OncoGenerix

Mudanjiang, Heilongjiang, China

Ownership: Private
Employees: ~24
Development stage: Other

Overview

OncoGenerix is a contract manufacturing organization (CMO) specializing in sterile injectable products for the pharmaceutical and biotech industries. Founded in 2009, the company operates a state-of-the-art facility in Mudanjiang, China, with FDA, EMA, and CFDA compliance. OncoGenerix USA serves as the exclusive distributor for services ranging from clinical supplies to commercial manufacturing. The company employs 24 people and provides a fully integrated suite of services including formulation, filling, lyophilization, and packaging.

Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on OncoGenerix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OncoGenerix.

Explore the full profile